Advanced
  Home Compare Reports

Comparison with Similar Reports

Corporate Wellness Solutions Market by Service Offering (HRA, Nutrition, Weight Loss, Fitness, Substance Abuse Management, Employee Assistance Program...

Publisher:        MarketsandMarkets

# of Pages:        225

Rating: 

1 User License $4,950

Publication Date:  June, 2021

Price:       $4,950 / User License




1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS AND EXCLUSIONS 25
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
FIGURE 1 CORPORATE WELLNESS SOLUTIONS MARKET SEGMENTATION 25
FIGURE 2 CORPORATE WELLNESS SOLUTIONS MARKET, BY REGION 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY 26
TABLE 1 STANDARD CURRENCY CONVERSION RATES 27
1.5 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH APPROACH 28
2.2 RESEARCH METHODOLOGY DESIGN 28
FIGURE 3 CORPORATE WELLNESS SOLUTIONS MARKET: RESEARCH DESIGN 28
2.2.1 SECONDARY RESEARCH 29
2.2.1.1 Key data from secondary sources 30
2.2.2 PRIMARY DATA 31
FIGURE 4 PRIMARY SOURCES 31
2.2.2.1 Key data from primary sources 32
2.2.2.2 Insights from primary experts 32
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY,
DESIGNATION, AND REGION 33
2.3 MARKET SIZE ESTIMATION 34
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34
FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION 35
FIGURE 9 REVENUE ANALYSIS OF THE TOP 3 PUBLIC COMPANIES: CORPORATE WELLNESS SOLUTIONS MARKET (2020) 35
FIGURE 10 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF CORPORATE WELLNESS SERVICES (US) 36
FIGURE 11 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF CORPORATE WELLNESS SERVICES (EUROPE) 37
FIGURE 12 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTH RISK ASSESSMENT SOLUTIONS (US) 38
FIGURE 13 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE CORPORATE WELLNESS SOLUTIONS MARKET (2021–2026) 40
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 41
FIGURE 15 TOP-DOWN APPROACH 41
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 42
FIGURE 16 DATA TRIANGULATION METHODOLOGY 42
2.5 MARKET SHARE ESTIMATION 43
2.6 ASSUMPTIONS FOR THE STUDY 43
2.7 LIMITATIONS 44
2.7.1 METHODOLOGY-RELATED LIMITATIONS 44
2.7.2 SCOPE-RELATED LIMITATIONS 44
2.8 RISK ASSESSMENT 45
TABLE 2 RISK ASSESSMENT: CORPORATE WELLNESS SOLUTIONS MARKET 45
3 EXECUTIVE SUMMARY 46
FIGURE 17 CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING,
2021 VS. 2026 (USD BILLION) 46
FIGURE 18 CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2021 VS. 2026 (USD BILLION) 47
FIGURE 19 GEOGRAPHIC SNAPSHOT: CORPORATE WELLNESS SOLUTIONS MARKET 48
4 PREMIUM INSIGHTS 49
4.1 CORPORATE WELLNESS SOLUTIONS MARKET OVERVIEW 49
FIGURE 20 INCREASED UPTAKE OF TECHNOLOGY-POWERED CORPORATE WELLNESS SOLUTIONS RESPONSIBLE FOR MARKET GROWTH 49
4.2 NORTH AMERICA: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING 50
FIGURE 21 IN NORTH AMERICA, LARGE ORGANIZATIONS COMMANDED THE LARGEST SHARE IN THE CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, IN 2020 50
4.3 CORPORATE WELLNESS SOLUTIONS MARKET: GEOGRAPHIC MIX 51
FIGURE 22 CHINA TO WITNESS THE HIGHEST GROWTH IN THE CORPORATE WELLNESS SOLUTIONS MARKET DURING THE FORECAST PERIOD 51
4.4 REGIONAL MIX: CORPORATE WELLNESS SOLUTIONS MARKET 52
FIGURE 23 NORTH AMERICA DOMINATED THE MARKET IN 2020 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
FIGURE 24 CORPORATE WELLNESS SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 53
5.2.1 MARKET DRIVERS 54
5.2.1.1 Rising adoption of corporate wellness programs 54
FIGURE 25 US: PERCENTAGE OF FIRMS PROVIDING HEALTH RISK ASSESSMENT SOLUTIONS (AMONG FIRMS OFFERING HEALTH BENEFITS), 2015–2019 54
5.2.1.2 Technology-powered corporate wellness solutions 55
FIGURE 26 US: PERCENTAGE OF FIRMS PROVIDING EMPLOYEES WITH WEARABLE TECHNOLOGIES AS PART OF THEIR HEALTH IMPROVEMENT PROGRAM,
BY FIRM SIZE, 2019 55
5.2.1.3 Substantial burden of chronic lifestyle diseases and mental health issues in organizations 55
FIGURE 27 TOTAL HEALTH EXPENDITURE ON DIABETES (USD MILLION), BY REGION, 2019 56
FIGURE 28 PERCENTAGE OF SMALL AND LARGE FIRMS OFFERING CORPORATE WELLNESS PROGRAMS IN THE US, 2019 57
5.2.2 MARKET RESTRAINTS 58
5.2.2.1 Dearth of qualified and licensed professionals to support corporate wellness programs 58
5.2.3 MARKET OPPORTUNITIES 58
5.2.3.1 Increased focus on employee health and wellbeing driven by the COVID-19 pandemic 58
5.2.3.2 Emerging countries with a large working population 59
5.2.4 MARKET CHALLENGES 59
5.2.4.1 Low employee engagement and participation in corporate wellness programs 59
5.2.4.2 Budgetary constraints 59
5.2.4.3 Adoption of internal employer-led wellness programs through benefits packages and perks 60
5.3 SCENARIOS: PESSIMISTIC, REALISTIC, AND OPTIMISTIC 60
5.3.1 CORPORATE WELLNESS SOLUTIONS MARKET 60
5.4 COVID-19 IMPACT ANALYSIS 61
5.4.1 COVID-19 HEALTH ASSESSMENT 61
5.5 COVID-19 ECONOMIC ASSESSMENT 61
5.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 61
FIGURE 29 CRITERIA IMPACTING THE GLOBAL ECONOMY 62
5.7 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE CORPORATE WELLNESS SOLUTIONS MARKET 63
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) 64
5.8.1 CORPORATE WELLNESS SOLUTIONS MARKET 64
5.8.1.1 Revenue sources are shifting towards more technology-based solutions due to the COVID-19 pandemic 64
FIGURE 30 REVENUE SHIFT IN THE CORPORATE WELLNESS SOLUTIONS MARKET 64
5.9 AVERAGE SELLING PRICE TREND 64
TABLE 3 AVERAGE PRICING OF CORPORATE WELLNESS SERVICE OFFERINGS,
BY REGION (USD) 65
5.10 ECOSYSTEM/MARKET MAP 65
TABLE 4 CORPORATE WELLNESS SOLUTIONS MARKET: ECOSYSTEM 65
5.11 PATENT ANALYSIS: BIOMETRIC SCREENING 66
FIGURE 31 LIST OF MAJOR PATENTS FOR BIOMETRIC SCREENING 66
5.12 CASE STUDY ANALYSIS 67
5.12.1 CASE STUDY 1: CORPORATE WELLNESS PROGRAMS LOWERING
THE RISK OF CHRONIC DISEASES IN EMPLOYEES 67
5.12.2 CASE STUDY 2: WORKPLACE MENTAL HEALTH STRATEGY 67
5.13 TECHNOLOGICAL ANALYSIS: WEARABLE TECHNOLOGY 67
5.13.1 KEY TECHNOLOGY 67
5.13.2 COMPLEMENTARY TECHNOLOGY 67
5.13.2.1 Medical wearable technology 67
5.13.3 ADJACENT TECHNOLOGY 68
5.13.3.1 IoT (Internet of Things) in healthcare 68
5.14 REGULATORY LANDSCAPE 68
5.14.1 NORTH AMERICA 68
5.14.2 EUROPE 69
5.15 PORTER’S FIVE FORCES ANALYSIS 70
FIGURE 32 PORTER’S FIVE FORCES ANALYSIS (2020): CORPORATE WELLNESS SOLUTIONS MARKET 70
TABLE 5 CORPORATE WELLNESS SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 70
5.15.1 THREAT FROM NEW ENTRANTS 71
5.15.1.1 Growth in the overall corporate wellness solutions industry 71
5.15.1.2 High labor intensity of the market 71
5.15.2 THREAT FROM SUBSTITUTES 71
5.15.2.1 Internal wellness programs designed by HR departments 71
5.15.2.2 Gyms and health clubs offering corporate wellness programs 71
5.15.3 BARGAINING POWER OF SUPPLIERS 71
5.15.3.1 Price sensitivity of the market 71
5.15.3.2 Large number of market players 71
5.15.4 BARGAINING POWER OF BUYERS 72
5.15.4.1 Low differentiation between service offerings and low switching costs 72
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 72
5.15.5.1 Similar services offered by market players 72
6 CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING 73
6.1 INTRODUCTION 74
TABLE 6 CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING,
2019–2026 (USD MILLION) 74
TABLE 7 CORPORATE WELLNESS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 75
6.2 HEALTH RISK ASSESSMENT 75
6.2.1 RISING ADOPTION OF HEALTH RISK ASSESSMENT SERVICES DUE TO THE COVID-19 PANDEMIC TO BOOST THE GROWTH OF THIS SEGMENT 75
TABLE 8 CORPORATE WELLNESS SOLUTIONS MARKET FOR HEALTH RISK ASSESSMENT, BY COUNTRY, 2019–2026 (USD MILLION) 77
6.3 NUTRITION AND WEIGHT MANAGEMENT 77
6.3.1 GROWING FOCUS ON NUTRITION AND WEIGHT MANAGEMENT BY EMPLOYERS TO REDUCE HEALTH RISK IN EMPLOYEES TO PROMOTE GROWTH IN THIS SEGMENT 77
TABLE 9 US: PERCENTAGE OF FIRMS OFFERING PROGRAMS TO LOSE WEIGHT (2019) 78
TABLE 10 NUTRITION AND WEIGHT MANAGEMENT SERVICES PROVIDED FOR CORPORATE WELLNESS PROGRAMS 78
TABLE 11 CORPORATE WELLNESS SOLUTIONS MARKET FOR NUTRITION AND WEIGHT MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION) 79
6.4 SMOKING CESSATION SERVICES 79
6.4.1 REDUCED HEALTHCARE COSTS WITH SMOKING CESSATION TO BOOST THE UPTAKE OF THESE SERVICES BY ORGANIZATIONS 79
TABLE 12 CORPORATE WELLNESS SOLUTIONS MARKET FOR SMOKING CESSATION SERVICES, BY COUNTRY, 2019–2026 (USD MILLION) 80
6.5 FITNESS SERVICES 80
6.5.1 RISING POPULARITY OF WEARABLE DEVICES IN CORPORATE FITNESS PROGRAMS DRIVING GROWTH IN THIS SEGMENT 80
TABLE 13 CORPORATE WELLNESS SOLUTIONS MARKET FOR FITNESS SERVICES,
BY COUNTRY, 2019–2026 (USD MILLION) 81
6.6 BIOMETRIC SCREENING 81
6.6.1 INCENTIVIZED BIOMETRIC SCREENING PROGRAMS MAY BOOST THE GROWTH OF THIS SEGMENT 81
FIGURE 33 US: PERCENTAGE OF FIRMS OFFERING BIOMETRIC SCREENING (AMONG THOSE OFFERING HEALTH BENEFITS) IN THE US, BY FIRM SIZE (2019) 82
TABLE 14 CORPORATE WELLNESS SOLUTIONS MARKET FOR BIOMETRIC SCREENING, BY COUNTRY, 2019–2026 (USD MILLION) 82
6.7 ALCOHOL AND SUBSTANCE ABUSE SERVICES 83
6.7.1 RISING INCIDENCE OF ALCOHOL & SUBSTANCE ABUSE IN THE COVID-19 PANDEMIC TO PROMOTE THE GROWTH OF THIS SEGMENT 83
FIGURE 34 US: PERCENTAGE OF FIRMS TAKING VARIOUS ACTIONS IN RESPONSE TO THE OPIOID CRISIS IN THE US, BY FIRM SIZE (2019) 83
TABLE 15 CORPORATE WELLNESS SOLUTIONS MARKET FOR ALCOHOL AND SUBSTANCE ABUSE SERVICES, BY COUNTRY, 2019–2026 (USD MILLION) 84
6.8 MENTAL/BEHAVIORAL HEALTH MANAGEMENT 84
6.8.1 PHONE/VIDEO COUNSELING AND WELLNESS PLATFORMS ENCOURAGE THE ADOPTION OF CORPORATE WELLNESS PROGRAMS FOCUSING ON MENTAL HEALTH MANAGEMENT 84
TABLE 16 CORPORATE WELLNESS SOLUTIONS MARKET FOR MENTAL/BEHAVIORAL HEALTH MANAGEMENT, BY COUNTRY, 2019–2026 (USD MILLION) 85
6.9 HEALTH EDUCATION SERVICES 85
6.9.1 HEALTH EDUCATION IS THE CORE AND KEY TO THE SUCCESS OF ANY CORPORATE WELLNESS PROGRAM—A KEY FACTOR DRIVING MARKET GROWTH 85
TABLE 17 CORPORATE WELLNESS SOLUTIONS MARKET FOR HEALTH EDUCATION SERVICES, BY COUNTRY, 2019–2026 (USD MILLION) 86
6.10 VIRTUAL CARE/CONSULTATION SERVICES 86
6.10.1 RISING ADOPTION AND COVERAGE OF VIRTUAL CARE/CONSULTATION IN HEALTH BENEFIT PROGRAMS BY EMPLOYERS TO BOOST THE GROWTH OF THIS MARKET 86
TABLE 18 CORPORATE WELLNESS SOLUTIONS MARKET FOR VIRTUAL CARE/CONSULTATION SERVICES, BY COUNTRY, 2019–2026 (USD MILLION) 87
 
6.11 EMPLOYEE ASSISTANCE PROGRAMS 87
6.11.1 NEED TO ENSURE HOLISTIC WELLBEING OF EMPLOYEES DRIVES THE GROWTH OF THIS SEGMENT 87
TABLE 19 EXAMPLES OF EMPLOYEE ASSISTANCE PROGRAMS PROVIDED BY CORPORATE WELLNESS SOLUTIONS MARKET PLAYERS 88
TABLE 20 CORPORATE WELLNESS SOLUTIONS MARKET FOR EMPLOYEE ASSISTANCE PROGRAMS, BY COUNTRY, 2019–2026 (USD MILLION) 88
6.12 HEALTH BENEFIT PROGRAMS 89
6.12.1 NEED FOR SEAMLESS NAVIGATION OF HEALTH BENEFITS BY EMPLOYEES PROPELLING THE GROWTH OF THIS SEGMENT 89
TABLE 21 EXAMPLES OF HEALTH BENEFIT PROGRAMS PROVIDED BY CORPORATE WELLNESS SOLUTIONS MARKET PLAYERS 89
TABLE 22 CORPORATE WELLNESS SOLUTIONS MARKET FOR HEALTH BENEFIT PROGRAMS, BY COUNTRY, 2019–2026 (USD MILLION) 89
7 CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER 90
7.1 INTRODUCTION 91
TABLE 23 CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 91
7.2 LARGE ORGANIZATIONS 91
7.2.1 HIGH UTILIZATION OF WORKPLACE WELLNESS PROGRAMS AND FAVORABLE INCENTIVIZATION TO PROMOTE THE GROWTH OF THIS SEGMENT 91
FIGURE 35 US: PERCENTAGE OF FIRMS IN THE US OFFERING INCENTIVES FOR PARTICIPATION IN CORPORATE WELLNESS PROGRAMS, BY FIRM SIZE (2019) 92
TABLE 24 CORPORATE WELLNESS SOLUTIONS MARKET FOR LARGE ORGANIZATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 92
7.3 MEDIUM-SIZED ORGANIZATIONS 93
7.3.1 RISING AWARENESS OF BENEFITS AND RETURNS ON INVESTMENT OF WELLNESS PROGRAMS TO BOOST THE GROWTH OF THIS END-USER SEGMENT 93
TABLE 25 CORPORATE WELLNESS SOLUTIONS MARKET FOR MEDIUM-SIZED ORGANIZATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 93
7.4 SMALL ORGANIZATIONS 94
7.4.1 RISING AFFORDABILITY AND FAVORABLE PAYMENT MODELS TO BOOST THE GROWTH OF THIS SEGMENT 94
TABLE 26 CORPORATE WELLNESS SOLUTIONS MARKET FOR SMALL ORGANIZATIONS, BY COUNTRY, 2019–2026 (USD MILLION) 94
8 CORPORATE WELLNESS SOLUTIONS MARKET, BY REGION 95
8.1 INTRODUCTION 96
FIGURE 36 GEOGRAPHIC SNAPSHOT OF THE CORPORATE WELLNESS SOLUTIONS MARKET 96
TABLE 27 CORPORATE WELLNESS SOLUTIONS MARKET, BY REGION,
2019–2026 (USD MILLION) 96
8.2 NORTH AMERICA 97
FIGURE 37 NORTH AMERICA: CORPORATE WELLNESS SOLUTIONS MARKET SNAPSHOT 98
TABLE 28 NORTH AMERICA: CORPORATE WELLNESS SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 99
TABLE 29 NORTH AMERICA: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 99
TABLE 30 NORTH AMERICA: CORPORATE WELLNESS SOLUTIONS MARKET,
BY END USER, 2019–2026 (USD MILLION) 100
8.2.1 US 100
8.2.1.1 Increasing prevalence of chronic disease and the rising opioid crisis to drive growth in the corporate wellness solutions market in the US 100
TABLE 31 US: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 101
TABLE 32 US: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 101
8.2.2 CANADA 102
8.2.2.1 Increasing mental health issues and substance abuse fueled by the COVID-19 pandemic to drive the demand for corporate wellness solutions in Canada 102
TABLE 33 CANADA: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 102
TABLE 34 CANADA: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 103
8.3 EUROPE 103
TABLE 35 EUROPE: CORPORATE WELLNESS SOLUTIONS MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 104
TABLE 36 EUROPE: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 104
TABLE 37 EUROPE: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 105
8.3.1 GERMANY 105
8.3.1.1 High prevalence of obesity and growing burden of substance abuse to increase the adoption of corporate wellness solutions in Germany 105
TABLE 38 GERMANY: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 106
TABLE 39 GERMANY: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 106
8.3.2 FRANCE 107
8.3.2.1 Growing absenteeism due to poor physical and mental wellbeing of employees to drive market growth in France 107
TABLE 40 FRANCE: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 107
TABLE 41 FRANCE: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 108
8.3.3 UK 108
8.3.3.1 Increasing work stress and the growing prevalence of obesity in the country to boost the demand for employee health and wellness solutions 108
TABLE 42 UK: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 109
TABLE 43 UK: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 109
8.3.4 ITALY 109
8.3.4.1 Growing demand for virtual care/consultation services in the country to drive market growth 109
TABLE 44 ITALY: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 110
TABLE 45 ITALY: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 110
8.3.5 SPAIN 111
8.3.5.1 High incidence of obesity and heart disease to drive the demand for nutrition and weight management and fitness services in Spain 111
TABLE 46 SPAIN: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 111
TABLE 47 SPAIN: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 112
8.3.6 REST OF EUROPE 112
TABLE 48 ROE: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 113
TABLE 49 ROE: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 113
8.4 ASIA PACIFIC 113
FIGURE 38 ASIA PACIFIC: CORPORATE WELLNESS SOLUTIONS MARKET SNAPSHOT 114
TABLE 50 ASIA PACIFIC: CORPORATE WELLNESS SOLUTIONS MARKET, BY COUNTRY, 2019–2026 (USD MILLION) 115
TABLE 51 ASIA PACIFIC: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 115
TABLE 52 ASIA PACIFIC: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 116
8.4.1 CHINA 116
8.4.1.1 Increasing number of lifestyle diseases, coupled with growing tobacco addiction, to drive the demand for corporate wellness solutions 116
TABLE 53 CHINA: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 117
TABLE 54 CHINA: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 117
8.4.2 JAPAN 117
8.4.2.1 Favorable regulations and increasing focus on workplace wellness to boost market growth in Japan 117
TABLE 55 JAPAN: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 118
TABLE 56 JAPAN: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 118
8.4.3 INDIA 119
8.4.3.1 Rising digitization of services and increasing penetration of smartphones and wearable devices to contribute to market growth 119
TABLE 57 INDIA: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 119
TABLE 58 INDIA: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 120
8.4.4 ROAPAC 120
TABLE 59 ROAPAC: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 121
TABLE 60 ROAPAC: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER, 2019–2026 (USD MILLION) 121
8.5 REST OF THE WORLD 121
TABLE 61 ROW: CORPORATE WELLNESS SOLUTIONS MARKET, BY SERVICE OFFERING, 2019–2026 (USD MILLION) 122
TABLE 62 ROW: CORPORATE WELLNESS SOLUTIONS MARKET, BY END USER,
2019–2026 (USD MILLION) 122
9 COMPETITIVE LANDSCAPE 123
9.1 INTRODUCTION 123
9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 123
9.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE CORPORATE WELLNESS SOLUTIONS MARKET 124
9.3 REVENUE SHARE ANALYSIS 125
9.3.1 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CORPORATE WELLNESS SOLUTIONS MARKET 125
FIGURE 39 REVENUE ANALYSIS FOR KEY PLAYERS IN THE CORPORATE WELLNESS SOLUTIONS MARKET IN THE PAST 5 YEARS 125
9.4 MARKET SHARE ANALYSIS 126
9.4.1 CORPORATE WELLNESS SOLUTIONS MARKET (2020) 126
FIGURE 40 SHARE OF LEADING COMPANIES IN THE GLOBAL CORPORATE WELLNESS SOLUTIONS MARKET (2020) 126
TABLE 63 CORPORATE WELLNESS SOLUTIONS MARKET: DEGREE OF COMPETITION 127
9.5 COMPANY EVALUATION QUADRANT 127
9.5.1 COMPANY EVALUATION QUADRANT: CORPORATE WELLNESS SOLUTIONS MARKET 127
FIGURE 41 GLOBAL CORPORATE WELLNESS SOLUTIONS MARKET COMPANY EVALUATION MATRIX, 2020 128
9.5.1.1 Stars 129
9.5.1.2 Pervasive players 129
9.5.1.3 Emerging leaders 129
9.5.1.4 Participants 129
9.5.1.5 Competitive benchmarking 130
9.5.1.5.1 Company product/service footprint (20 companies) 130
TABLE 64 COMPANY SERVICE OFFERING FOOTPRINT (20 COMPANIES) 131
TABLE 65 COMPANY END-USER FOOTPRINT (20 COMPANIES) 132
TABLE 66 COMPANY REGION FOOTPRINT (20 COMPANIES) 133
9.6 COMPETITIVE SITUATIONS AND TRENDS 134
9.6.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 134
TABLE 67 PRODUCT/SERVICE LAUNCHES (2018–MAY 2021) 134
9.6.2 DEALS 136
TABLE 68 DEALS (2018–MAY 2021) 136
TABLE 69 OTHER DEVELOPMENTS (2018–MAY 2021) 137
10 COMPANY PROFILES 138
10.1 KEY PLAYERS 138
10.1.1 COMPSYCH CORPORATION 138
10.1.1.1 Business overview 138
TABLE 70 COMPSYCH CORPORATION: BUSINESS OVERVIEW 138
10.1.1.2 Products & services offered 139
10.1.1.3 Recent developments 140
10.1.1.4 MnM view 140
10.1.1.4.1 Right to win 141
10.1.1.4.2 Strategic choices made 141
10.1.2 UNITEDHEALTH GROUP (OPTUM) 142
10.1.2.1 Business overview 142
TABLE 71 UNITEDHEALTH GROUP: BUSINESS OVERVIEW 142
FIGURE 42 UNITEDHEALTH GROUP: COMPANY SNAPSHOT (2020) 143
FIGURE 43 OPTUM: COMPANY SNAPSHOT (2020) 144
10.1.2.2 Products & services offered 144
10.1.2.3 Recent developments 148
10.1.2.4 MnM view 149
10.1.2.4.1 Right to win 150
10.1.2.4.2 Strategic choices made 150
10.1.3 ANTHEM, INC. 151
10.1.3.1 Business overview 151
TABLE 72 ANTHEM, INC.: BUSINESS OVERVIEW 151
FIGURE 44 ANTHEM, INC.: COMPANY SNAPSHOT (2020) 152
10.1.3.2 Products & services offered 153
10.1.3.3 Recent developments 154
10.1.3.4 MnM view 154
10.1.3.4.1 Right to win 154
10.1.3.4.2 Strategic choices made 154
10.1.4 WORKPLACE OPTIONS 155
10.1.4.1 Business overview 155
TABLE 73 WORKPLACE OPTIONS: BUSINESS OVERVIEW 155
10.1.4.2 Products & services offered 156
10.1.4.3 Recent developments 159
10.1.4.4 MnM view 160
10.1.4.4.1 Right to win 160
10.1.4.4.2 Strategic choices made 160
10.1.5 VIRGIN GROUP LTD. (VIRGIN PULSE) 161
10.1.5.1 Business overview 161
 
TABLE 74 VIRGIN GROUP LTD.: BUSINESS OVERVIEW 161
TABLE 75 VIRGIN PULSE: BUSINESS OVERVIEW 161
10.1.5.2 Products & services offered 162
10.1.5.3 Recent developments 163
10.1.6 CVS HEALTH CORPORATION 165
10.1.6.1 Business overview 165
TABLE 76 CVS HEALTH CORPORATION: BUSINESS OVERVIEW 165
FIGURE 45 CVS HEALTH CORPORATION: COMPANY SNAPSHOT (2020) 166
10.1.6.2 Products & services offered 166
10.1.6.3 Recent developments 167
10.1.7 CLEVELAND CLINIC 168
10.1.7.1 Business overview 168
TABLE 77 CLEVELAND CLINIC: BUSINESS OVERVIEW 168
FIGURE 46 CLEVELAND CLINIC: COMPANY SNAPSHOT (2020) 168
10.1.7.2 Products & services offered 169
10.1.7.3 Recent developments 171
10.1.8 EXOS 173
10.1.8.1 Business overview 173
TABLE 78 EXOS: BUSINESS OVERVIEW 173
10.1.8.2 Products & services offered 173
10.1.8.3 Recent developments 174
10.1.9 CERNER CORPORATION 175
10.1.9.1 Business overview 175
TABLE 79 CERNER CORPORATION: BUSINESS OVERVIEW 175
FIGURE 47 CERNER CORPORATION: COMPANY SNAPSHOT (2020) 176
10.1.9.2 Products & services offered 176
10.1.9.3 Recent developments 178
10.1.10 ALPHABET INC. (FITBIT) 179
10.1.10.1 Business overview 179
TABLE 80 GOOGLE LLC: BUSINESS OVERVIEW 179
FIGURE 48 ALPHABET, INC.: COMPANY SNAPSHOT (2020) 180
FIGURE 49 FITBIT, INC.: COMPANY SNAPSHOT (2019) 181
10.1.10.2 Products & services offered 181
10.1.10.3 Recent developments 182
10.1.11 LABORATORY CORPORATION OF AMERICA HOLDINGS 184
10.1.11.1 Business overview 184
TABLE 81 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW 184
FIGURE 50 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2020) 185
10.1.11.2 Products & services offered 185
10.1.11.3 Recent developments 187
10.1.12 LIFEWORKS, INC. 188
10.1.12.1 Business overview 188
TABLE 82 LIFEWORKS, INC.: BUSINESS OVERVIEW 188
FIGURE 51 LIFEWORKS, INC.: COMPANY SNAPSHOT (2020) 189
10.1.12.2 Products & services offered 189
10.1.12.3 Recent developments 191
10.1.12.4 MnM view 194
10.1.12.4.1 Right to win 194
10.1.12.4.2 Strategic choices made 194
10.1.13 CENTENE CORPORATION (MANAGED HEALTH NETWORK, INC.) 195
10.1.13.1 Business overview 195
TABLE 83 CENTENE CORPORATION: BUSINESS OVERVIEW 195
TABLE 84 MANAGED HEALTH NETWORK, INC.: BUSINESS OVERVIEW 195
FIGURE 52 CENTENE CORPORATION: COMPANY SNAPSHOT (2020) 196
10.1.13.2 Products & services offered 196
10.1.14 TELUS 198
10.1.14.1 Business overview 198
TABLE 85 TELUS: BUSINESS OVERVIEW 198
FIGURE 53 TELUS: COMPANY SNAPSHOT (2020) 199
10.1.14.2 Products & services offered 199
10.1.14.3 Recent developments 201
10.1.14.4 MnM view 202
10.1.14.4.1 Right to win 202
10.1.14.4.2 Strategic choices made 202
10.1.15 DISCOVERY LIMITED (VITALITY GROUP INTERNATIONAL, INC.) 203
10.1.15.1 Business overview 203
TABLE 86 DISCOVERY LIMITED: BUSINESS OVERVIEW 203
TABLE 87 VITALITY GROUP: BUSINESS OVERVIEW 203
FIGURE 54 DISCOVERY LIMITED: COMPANY SNAPSHOT (2020) 204
10.1.15.2 Products & services offered 204
10.1.15.3 Recent developments 205
10.2 OTHER EMERGING COMPANIES 207
10.2.1 WELLRIGHT 207
10.2.1.1 Business overview 207
TABLE 88 WELLRIGHT: BUSINESS OVERVIEW 207
10.2.1.2 Products & services offered 207
10.2.1.3 Recent developments 208
10.2.2 MEDCAN 209
10.2.2.1 Business overview 209
TABLE 89 MEDCAN: BUSINESS OVERVIEW 209
10.2.2.2 Products & services offered 209
10.2.2.3 Recent developments 210
 
10.2.3 SHARECARE 211
10.2.3.1 Business overview 211
TABLE 90 SHARECARE: BUSINESS OVERVIEW 211
10.2.3.2 Products & services offered 211
10.2.4 GILSBAR 213
10.2.4.1 Business overview 213
TABLE 91 GILSBAR: BUSINESS OVERVIEW 213
10.2.4.2 Products & services offered 213
10.2.5 LIMEADE 214
10.2.5.1 Business overview 214
TABLE 92 LIMEADE: BUSINESS OVERVIEW 214
FIGURE 55 LIMEADE: COMPANY SNAPSHOT (2020) 215
10.2.5.2 Products & services offered 215
10.2.5.3 Recent developments 216
10.2.6 TOTALWELLNESS 217
10.2.7 WELLSTEPS 218
10.2.8 ADURO, INC. 218
10.2.9 CORPORATE FITNESS WORKS 219
10.2.10 WELLWORKS FOR YOU 220
11 APPENDIX 221
11.1 DISCUSSION GUIDE 221
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 225
11.3 AVAILABLE CUSTOMIZATIONS 227
11.4 RELATED REPORTS 227
11.5 AUTHOR DETAILS 228

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127